AzTrials
AzTrials

Chronic PainMBCT-TIPNCT07700355

Mindfulness Therapy for Chronic Pain After Intimate Partner Violence

A study testing Mindfulness-Based Cognitive Therapy for Trauma-Informed Pain (MBCT-TIP) and Health Enhancement Program (HEP) in people with Chronic Pain, run by Brigham and Women's Hospital at 1 site in United States.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this clinical trial is to develop and test a new program called MBCT-TIP for adults with chronic pain and a history of intimate partner violence (IPV). MBCT-TIP combines mindfulness-based cognitive therapy with a trauma-informed approach to pain. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Chronic Pain
What is being tested?
Mindfulness-Based Cognitive Therapy for Trauma-Informed Pain (MBCT-TIP) and Health Enhancement Program (HEP)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
58 participants
Where
1 siteUnited States
Study dates
Jul 2027to Aug 2031
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age 18 or older
  • Primary care patient at Fish Center or other Mass General Brigham (MGB) primary care clinic
  • Diagnosis of chronic primary pain (≥3 months), per ICD-11 criteria
  • Pain severity of ≥4 on the Numeric Pain Rating Scale (NRS)
  • History of intimate partner violence (IPV), e.g., via the Abuse Assessment Screen (AAS)

Who cannot join

  • Significant change in psychiatric medication or therapy in the past 3 months
  • Untreated or poorly controlled severe mental health disorder(s)
  • Active or high suicide risk in the past 90 days (via PHQ-9 item #9 or otherwise reported, with subsequent risk assessment as needed)
  • Untreated or poorly controlled PTSD, as assessed by the Primary Care PTSD Screen or clinically by the primary care provider (PCP) or consulting psychiatrist
  • Untreated or poorly controlled substance use disorder that, per patient self-report or the primary care team, would interfere with the ability to participate
  • Moderate-to-severe cognitive impairment or inability to provide informed consent
Show all 9Show fewer
  • Inability to consistently participate in sessions
  • Lack of verbal and written English fluency
  • Otherwise deemed by referring PCP to be inappropriate for inclusion

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Rose M Olson, MD, MPH contact

617-983-7000

rolson@bwh.harvard.edu

United States1 site
  • Brigham and Women's Fish Center for Women's Health

    Boston, Massachusetts, 02467

    Rose M Olson, MD, MPH, 617-983-7000, rolson@bwh.harvard.edu

    Rose M Olson, MD, MPH

Other trials in United States

About this study

Official title: A Primary Care-Based Adaptation of MBCT for Chronic Pain After Intimate Partner Violence (MBCT-TIP): A Development and Feasibility Study

The goal of this clinical trial is to develop and test a new program called MBCT-TIP for adults with chronic pain and a history of intimate partner violence (IPV). MBCT-TIP combines mindfulness-based cognitive therapy with a trauma-informed approach to pain.

The main question this study aims to answer is:

Read more

Will MBCT-TIP be feasible and acceptable for adults with chronic pain and IPV histories?

Researchers will compare MBCT-TIP to a control - Health Enhancement Program (HEP). Comparing the two will help researchers see whether MBCT-TIP is feasible and acceptable for people with chronic pain and a history of IPV.

Participants will:

Attend 8 weekly group sessions, held in person, lasting about 1 hour each. Complete study assessments before starting the program, after finishing the program, and 3 months later

Read the detailed description

Chronic primary pain is highly prevalent among adults with histories of intimate partner violence (IPV), and existing behavioral pain treatments often perform poorly in this population because they do not address trauma-related mechanisms driving chronic pain in this population. Standard MBCT targets two pain-maintaining mechanisms - pain catastrophizing (PCS) and movement avoidance/kinesiophobia (TSK), but does not directly address trauma-related avoidance or include trauma-informed safety features.

MBCT-TIP retains MBCT's core pain-focused components and adds trauma-informed content aimed at trauma-related avoidance (measured via the Posttraumatic Avoidance Behavior Questionnaire (PABQ)).

By integrating MBCT-TIP into primary care, the most common point of contact for adults with chronic pain and IPV histories, this work has the potential to reduce pain interference and post-traumatic stress symptoms in a highly prevalent, often undertreated population

Conditions
Chronic Pain
Being tested
Mindfulness-Based Cognitive Therapy for Trauma-Informed Pain (MBCT-TIP), Health Enhancement Program (HEP)
Keywords
Chronic Pain, Intimate Partner Violence, mindfullness, Therapy, Trauma Informed care, Trauma, Primary care, Primary care based therapy, Mindfulness-based cognitive therapy, Mind-body intervention
Medical subject headings
Chronic Pain, Wounds and Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mindfulness-Based Cognitive Therapy for Trauma-Informed Pain (MBCT-TIP)Behavioural

    MBCT-TIP (MBCT for Trauma-Informed Pain)-a primary-care intervention for adults with chronic primary pain and IPV histories-retaining MBCT core elements while adding trauma-specific content to improve effectiveness and feasibility/acceptability.

  • Health Enhancement Program (HEP)Behavioural

    Health Enhancement Program (HEP) is an evidence-based intervention consisting of 8 weekly group-format sessions, each lasting 1 hour. It has been validated in previous studies for testing the efficacy of mindfulness-based interventions (MBIs) while focusing on non-mindfulness goals such as physical activity, sleep, nutrition, and social support.

Study groups in NCT07700355
Study groupRoleWhat they receive
Mindfulness-Based Cognitive Therapy for Trauma-Informed Pain (MBCT-TIP)ExperimentalMBCT-TIP will consist of 8 weekly group sessions (final session duration/delivery format to be determined from Aim 1 - Focus Group Discussion and Qualitative analysis). We will use the ADAPT-ITT framework to identify trauma-specific adaptations to MBCT.
Receives: Behavioral: Mindfulness-Based Cognitive Therapy for Trauma-Informed Pain (MBCT-TIP)
Health Enhancement Program (HEP)Active comparatorHealth Enhancement Program (HEP) is an evidence-based intervention consisting of 8 weekly group-format sessions, each lasting 1 hour. It has been validated in previous studies for testing the efficacy of mindfulness-based interventions (MBIs) while focusing on non-mindfulness goals such as physical activity, sleep, nutrition, and social support.
Receives: Behavioral: Health Enhancement Program (HEP)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain interference

    Change in pain interference as measured by the PROMIS Pain Interference Scale, which assesses the degree to which pain interferes with daily activities over the past 7 days.

    Measured: Change from Baseline (pre-treatment), post-treatment (approximately 8-10 weeks), and 3-month follow-up

Secondary outcomes (1)
  1. Post-Traumatic Stress - PTSD Checklist for DSM-5 (PCL-5)

    Change in post-traumatic stress symptom severity as measured by the PTSD Checklist for DSM-5 (PCL-5), which assesses symptoms of re-experiencing, avoidance, and arousal/reactivity.

    Measured: Baseline (pre-treatment), post-treatment (approximately 8-10 weeks), and 3-month follow-up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Jul 2026
  2. Study startJul 2027 (estimated)
  3. Primary completionSep 2030 (estimated)
  4. Study completionAug 2031 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Aim 2 (Single Group): We will conduct a single-arm, open pilot study of MBCT-TIP, with all participants receiving the intervention. Aim 3 (Parallel): We will conduct a pilot feasibility RCT comparing MBCT-TIP to an active control, the Health Enhancement Program (HEP).
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
58 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07700355
Sponsor's protocol ID
2026P001804
Acronym
MBCT-TIP
Status last verified
Jul 2026
First submitted
9 Jul 2026
Last updated
14 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Sensitive population.

Questions about this trial

What is this clinical trial studying?

A study testing Mindfulness-Based Cognitive Therapy for Trauma-Informed Pain (MBCT-TIP) and Health Enhancement Program (HEP) in people with Chronic Pain, run by Brigham and Women's Hospital at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 14 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Rose M Olson, MD, MPH (617-983-7000, rolson@bwh.harvard.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain interference (time frame: Change from Baseline (pre-treatment), post-treatment (approximately 8-10 weeks), and 3-month follow-up). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in